Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Longitudinal JCV serology in multiple sclerosis patients preceding natalizumab-associated progressive multifocal leukoencephalopathy.
Expression and regulation of human endogenous retrovirus W elements.
Opexa Therapeutics Announces Tcelna™ as New Brand Name for MS Therapy
Encephalitis followed by optic neuritis: a case report and review of literature.
Systematic review of occupational therapy-related interventions for people with multiple sclerosis: part 2. Impairment.
Post trauma vision syndrome and visual midline shift syndrome.
Robot-assisted vs. sensory integration training in treating gait and balance dysfunctions in patients with multiple sclerosis: a randomized controlled trial.
Safety and efficacy of natalizumab in Belgian multiple sclerosis patients: subgroup analysis of the natalizumab observational program.
Role of Chlamydia in Multiple Sclerosis.
Cost-Effectiveness Analysis of Delayed-Release Dimethyl Fumarate for The Treatment of Relapsing Remitting Multiple Sclerosis In Spain.
FTY720 immunosuppression impairs effector T cell peripheral homing without affecting induction, expansion, and memory.
Assay selection affects John Cunningham virus serostatus classification in multiple sclerosis.
Further validation of Multiple Sclerosis Walking Scale-12 scores based on spatiotemporal gait parameters.
A novel data mining system points out hidden relationships between immunological markers in multiple sclerosis.
[Assessment of the risk of the transition of a monofocal clinically isolated syndrome to clinically definite multiple sclerosis.]
Methodology of an International Study of People with Multiple Sclerosis Recruited through Web 2.0 Platforms: Demographics, Lifestyle, and Disease Characteristics.
Multiple sclerosis coexisting with spinal cord ependymoma: a case report.
Tumefactive demyelinating lesions: A Clinicopathological correlative study.
Environmental exposures and the risk of multiple sclerosis investigated in a Norwegian case-control study.
B lymphocytes in neuromyelitis optica.
Behavioural and molecular consequences of chronic cannabinoid treatment in Huntington's disease transgenic mice.
Lower urinary tract symptoms and urodynamic dysfunction in clinically isolated syndromes suggestive of multiple sclerosis.
Towards therapeutic applications of arthropod venom k(+)-channel blockers in CNS neurologic diseases involving memory acquisition and storage.
Comparison of MERGE and Axial T2-Weighted Fast Spin-Echo Sequences for Detection of Multiple Sclerosis Lesions in the Cervical Spinal Cord.
Multiple sclerosis in diverse populations: characteristics in distinct Arab ethnicities in Israel.
Pages
« first
‹ previous
…
278
279
280
281
282
283
284
285
286
…
next ›
last »